Liraglutide (Victoza, Saxenda)
A once-daily GLP-1 shot for type 2 diabetes (Victoza) and weight management (Saxenda). Generic versions are available.
- Evidence
- Extensive clinical research
- Half-life
- ~13 hours
- Sources
- 3 cited
Is liraglutide FDA-approved?
FDA-approved as Victoza (2010, type 2 diabetes) and Saxenda (2014, weight management; teens 12+ since 2020).
Overview
Liraglutide was one of the first GLP-1 medicines. In the SCALE trial, adults without diabetes on the weight-management dose lost about 8% of their body weight over a year, versus about 2.6% on placebo. In the LEADER trial it lowered heart attacks, strokes and heart-related deaths in people with type 2 diabetes and high heart risk.
How it works
Like other GLP-1 medicines, it boosts insulin when blood sugar is high, slows the stomach and reduces appetite. It's shorter-acting than semaglutide, so it's taken every day.
How long does liraglutide stay in the body?
About 13 hours. Levels peak 8–12 hours after a shot, which is why it's a daily medicine.
What it's studied for
- Type 2 diabetes
- Weight management in adults and teens
- Heart outcomes in type 2 diabetes
Reported side effects
- Nausea, diarrhea, constipation, vomiting, headache
- Faster resting heart rate
- Gallbladder problems and pancreatitis (rare)
- Boxed warning: thyroid C-cell tumors seen in rodents. Not for people with a personal or family history of medullary thyroid cancer or MEN 2.
How should liraglutide be stored?
Fridge before first use; after that, up to 30 days at room temperature or in the fridge.
Related: Semaglutide, Dulaglutide, Exenatide, Tirzepatide.
Sources
The studies and prescribing labels this page is written from.
- A Randomized, Controlled Trial of Liraglutide in Weight Management (SCALE). N Engl J Med, 2015 PubMed
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER). N Engl J Med, 2016 PubMed
- Saxenda (liraglutide) prescribing information. DailyMed DailyMed